These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 14175997)

  • 41. The detection of poliovirus and other enteric viruses in flies. Results of tests carried out during an oral poliovirus vaccine trial.
    RIORDAN JT; PAUL JR; YOSHIOKA I; HORSTMANN DM
    Am J Hyg; 1961 Sep; 74():123-36. PubMed ID: 14492407
    [No Abstract]   [Full Text] [Related]  

  • 42. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINE. III. IS THERE INTERFERENCE BY SV 40 AGAINST POLIOVIRUS?].
    GUENTHER O; VON METTENHEIM ; HOEVEL H
    Zentralbl Bakteriol Orig; 1964 Feb; 192():1-11. PubMed ID: 14176847
    [No Abstract]   [Full Text] [Related]  

  • 43. Review of the Louisiana State Board of Health experience with the use of Salk vaccine and comments on the Sabin oral polio vaccine.
    HEDMEG A
    J La State Med Soc; 1963 Feb; 115():41-7. PubMed ID: 13963684
    [No Abstract]   [Full Text] [Related]  

  • 44. [Virological studies and clinical observations following oral poliomyelitis vaccination (Sabin type 1)].
    HAAS R; THOMSSEN R; MAASS G; BADRAN M; VIVELL O; SUETTERLE H
    Dtsch Med Wochenschr; 1963 Mar; 88():557-64. PubMed ID: 13951607
    [No Abstract]   [Full Text] [Related]  

  • 45. [EXPERIENCES WITH THE WECKER TEST FOR IDENTIFICATION OF POLIOMYELITIS VIRUSES].
    VOSS H
    Zentralbl Bakteriol Orig; 1963 Dec; 191():108-12. PubMed ID: 14119889
    [No Abstract]   [Full Text] [Related]  

  • 46. THE PROPERTIES OF A NEW TYPE 3 ATTENUATED POLIOVIRUS. I. DERIVATION OF NEW TYPE 3 ATTENUATED POLIOVIRUSES AND THEIR LABORATORY CHARACTERISTICS.
    VONKA V; JANDA Z; SIMON J
    Arch Gesamte Virusforsch; 1964 Jun; 14():599-610. PubMed ID: 14247356
    [No Abstract]   [Full Text] [Related]  

  • 47. [THE PERSISTENCE OF POLIOMYELITIS VIRUS TYPE 1 IN VACCINATED INDIVIDUALS AND IN THEIR ENVIRONMENT].
    BILEK M; KOEENIG I; LUTYNSKI R
    Przegl Epidemiol; 1965; 19():97-100. PubMed ID: 14317139
    [No Abstract]   [Full Text] [Related]  

  • 48. Measurement of the protective effect of attenuated poliovirus vaccine.
    KNOWELDEN J; HALE JH; GARDNER PS; LEE LH
    Br Med J; 1961 May; 1(5237):1418-20. PubMed ID: 13757211
    [No Abstract]   [Full Text] [Related]  

  • 49. [POLIOMYELITIS-LIKE PARALYTIC DISEASE IN CHILDREN INOCULATED WITH SABIN LIVE VACCINE].
    BARTOSHEVICH EN; TSUKER MB; LESHCHINSKAIA EV; SOKOLOVA IS; MARTYNENKO IN; ANDREEVA LS; ASHMARINA EE
    Vestn Akad Med Nauk SSSR; 1963; 18():16-21. PubMed ID: 14064651
    [No Abstract]   [Full Text] [Related]  

  • 50. POLIOMYELITIS IN UDAIPUR. A SMALL OUTBREAK IN 1963 AND THE USE OF SABIN VACCINE.
    SINGH S; MEHERHOMJI KM; GHARPURE PV
    J Indian Med Assoc; 1964 Aug; 43():153-9. PubMed ID: 14194411
    [No Abstract]   [Full Text] [Related]  

  • 51. The influence of previous vaccination with killed vaccine on the susceptibility of the alimentary tract to infection with poliomyelitis virus.
    WILTERDINK JB; VERLINDE JD
    Arch Gesamte Virusforsch; 1963; 12():441-54. PubMed ID: 14001111
    [No Abstract]   [Full Text] [Related]  

  • 52. Role of live attenuated poliovirus vaccine.
    SKINNER RG
    J Fla Med Assoc; 1960 May; 46():1387-9. PubMed ID: 13831482
    [No Abstract]   [Full Text] [Related]  

  • 53. [APROPOS OF VACCINAL COMPLICATIONS AFTER ORAL POLIOMYELITIS VACCINATION THE PREVIOUS YEAR].
    SOLLBERG G
    Nervenarzt; 1964 Jul; 35():308-9. PubMed ID: 14257125
    [No Abstract]   [Full Text] [Related]  

  • 54. [ON THE VIABILITY AND RESISTANCE OF VACCINAL STRAINS OF POLIOVIRUSES IN THE EXTERNAL ENVIRONMENT].
    BYCHKOVSKAIA OV; BABINA NS; IVANOVA OD; KISELEVA LF
    Gig Sanit; 1964 Aug; 29():45-9. PubMed ID: 14249261
    [No Abstract]   [Full Text] [Related]  

  • 55. [ORAL ANTIPOLIOMYELITIC VACCINATION ACCORDING TO SABIN AND ITS APPLICATION IN ITALY].
    MIDULLA M
    Prog Med (Napoli); 1964 Jan; 20():37-46. PubMed ID: 14214814
    [No Abstract]   [Full Text] [Related]  

  • 56. [CAN ORAL VACCINATION AGAINST POLIOMYELITIS BE EFFECTIVE IN SKIN DISEASES?].
    SCHMITZ R
    Med Welt; 1963 Nov; 45():2301-2. PubMed ID: 14095426
    [No Abstract]   [Full Text] [Related]  

  • 57. [Cerebrospinal fluid studies after oral poliomyelitis vaccination (Sabin) in adults].
    HABECK D; LENZ E; PAAL G
    Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr; 1963; 204():389-403. PubMed ID: 13951620
    [No Abstract]   [Full Text] [Related]  

  • 58. [COMPARATIVE ATTEMPTS TO DEMONSTRATE ANTIBODIES AGAINST POLIOMYELITIS VIRUS WITH THE NEUTRALIZATION TEST AND THE IMMUNOFLUORESCENCE METHOD].
    BOSELLA F
    Boll Ist Sieroter Milan; 1964; 43():249-52. PubMed ID: 14199041
    [No Abstract]   [Full Text] [Related]  

  • 59. MASS IMMUNISATION AGAINST POLIOMYELITIS IN CEYLON IN 1962 USING SABIN ORAL VACCINE.
    ARUMANAYAGAM P
    J Trop Med Hyg; 1965 May; 68():105-9. PubMed ID: 14287300
    [No Abstract]   [Full Text] [Related]  

  • 60. [VACCINATION WITH LIVER POLIOMYELITIS VACCINE (SABIN). VIROLOGICAL AND SEROLOGICAL CONTROL OF MASS VACCINATIONS PERFORMED IN THE CZECHOSLOVAKIAN SSR DURING 1958-59 AND IN 1960].
    ZACEK K; ADAM E; ADAMOVA V; BURIAN V; REZACOVA D; SKRIDLOVSKA E; VANECKOVA N; VONKA V
    Cas Lek Cesk; 1963 Nov; 102():1257-68. PubMed ID: 14111749
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.